Doravirine
1 NDC across 1 manufacturer|0 Generic,1 Brand
▸ More about this market▾ Less
The brand product was first FDA-approved on Aug 30, 2018. In 2024, Medicare Part D spent $79 million on Doravirine across 42,000 claims for 4,774 beneficiaries.
Doravirine is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $60.70 to $60.70 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$60.70 – $60.70
per EA
7d Activity
avg -0.1% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing DORAVIRINE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
PIFELTRO 100 MG TABLET | $60.7003 per EA | -0.12% |
Frequently Asked Questions
How much does Medicare spend on Doravirine?
In 2024, Medicare Part D spent $79 million on Doravirine across 42,000 claims for 4,774 beneficiaries.
How many Doravirine products are on the market?
The Doravirine drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Doravirine?
NADAC reference prices for Doravirine range from $60.7003 to $60.7003 per EA.
Which manufacturers make Doravirine?
1 manufacturer lists Doravirine in NADAC. Ranked by number of NDCs, the largest are Merck Sharp & Dohme LLC (1).
How has the price of Doravirine changed recently?
Over the past 7 days, 0 Doravirine NDCs rose and 1 fell, with a market-wide average change of -0.1%.